Application of continuous amnioinfusion via a subcutaneous port system for premature rupture of membranes and at less than 28 weeks of gestation. The first experience in Russia

DOI: https://dx.doi.org/10.18565/aig.2017.12.141-147

Tskhai V.B., Naberezhnev Yu.I., Chirikov M.N., Lobanova T.T., Dudina A.Yu., Golovchenko O.V.

1 Department of Perinatology, Obstetrics, and Gynecology, Faculty of General Medicine, Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russian Federation, Krasnoyarsk 660022, P. Zheleznyaka str. 1, Russia; 2 Krasnoyarsk Territorial Clinical Center of Maternity and Child Care, Krasnoyarsk 600074, Academician Kirensky str. 2A, Russia; 3 Department of Genetics, Cytology, and Bioengineering, Voronezh State University, Voronezh 394018, Universitetskaya pl. 1, Russia; 4 University Clinic of Obstetrics and Fetal Medicine, University Medical Center Halle, Martin Luther University of Halle-Wittenberg, Halle, Germany, Ernst-Grube Strasse 40, DE-06120; 5 Department of Obstetrics and Gynecology, Belgorod State National Research University, Belgorod 308015, Pobeda str. 85, Russia
Premature rupture of membranes (PROM) is one of the major causes of high neonatal mortality and morbidity. Very preterm PROM, fetal pulmonary hypoplasia, and fetal inflammatory response syndrome are associated with the loss of amniotic fluid and the development of oligo/anhydramnios.
Objective. To extend the duration of pregnancy prolongation without increasing the infection risk with continuous amnioinfusion via a subcutaneous port system.
Materials and methods. A patient with PROM at 25 weeks’ gestation had continuous amnioinfusion (100 ml/h, 2400 ml/day, SDP (4±2 cm)) via a subcutaneous port, by using a hypotonic solution by the properties similar to those of amniotic fluid.
Conclusion. The first experience with continuous amnioinfusion allowed us to increase the interval of pregnancy prolongation up to 10 days in PROM. This new method can certainly be used in pregnant women with PROM and oligo/anhydramnios at term < 28/0 weeks of gestation.

Supplementary Materials


References


1. Audra P., Le Garrec M. Rupture prématurée des membranes à terme et avant terme. EMC, Obstétrique. 2010; 5(4): 1-19.

2. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet. 2008; 371(9606): 75-84.

3. Дятлова Л.И. Факторы риска преждевременного излития околоплодных вод при беременности 22-34 недели. Международный журнал экспериментального образования. 2015; 4-2: 312-22. [Dyatlova L.I. The risk factors of premature lithium amnioticed waters during pregnancy 22-34 weeks. International Journal of Experimental Education. 2015; 4-2: 312-22. (in Russian)]

4. Tchirikov M., Bapayeva G., Zhumadilov Z.Sh., Dridi Y., Harnisch R., Herrmann A. Treatment of PPROM with anhydramnion in humans: first experience with different amniotic fluid substitutes for continuous amnioinfusion through a subcutaneously implanted port system. J. Perinat. Med. 2013; 41(6): 657-63.

5. Jung E.Y., Park K.H., Lee S.Y., Ryu A., Oh K.J. Non-invasive prediction of intra-amniotic infection and/or inflammation in patients with cervical insufficiency or an asymptomatic short cervix (≤15 mm). Arch. Gynecol. Obstet. 2015; 292(3): 579-87.

6. Афанасиева М.Х., Болотских В.М., Полякова В.О. Преждевременное излитие околоплодных вод (современные взгляды на этиологию и патогенез, перспективы прогнозирования). Журнал акушерства и женских болезней. 2014; 63(3): 4-11. [Afanasieva H., Bolotskikh V.M., Poliakova V.O. Premature discharge amniotic fluid (modern views on etiology and pathogenesis, prospects for prediction). Journal of Obstetrics and women’s illnesses. 2014; 3: 4-11. (Russian)]

7. Болотских В.М., Милютина Ю.П. Преждевременное излитие околоплодных вод: иммунологические и биохимические аспекты проблемы, вопросы диагностики и тактики ведения. Журнал акушерства и женских болезней. 2011; 60(4): 104-16. [Bolotskikh V.M., Milutina J.P. Premature discharge amniotic waters: immunological and biochemical aspects of the problem, diagnostics and maintenance tactics. Journal of Obstetrics and women’s illnesses. 2011; 4: 104-116. (Russian)]

8. Jung E.Y., Choi B.Y., Rhee J., Park J., Cho S.H., Park K.H. Relation between amniotic fluid infection or cytokine levels and hearing screen failure in infants at 32 wk gestation or less. Pediatr. Res. 2017; 81(2): 349-55.

9. Armstrong-Wells J., Donnelly M., Post M.D., Manco-Johnson M.J., Winn V.D., Sébire G. Inflammatory predictors of neurologic disability after preterm premature rupture of membranes. Am. J. Obstet. Gynecol. 2015; 212(2): 212. e1-9.

10. Yin N., Wang H., Zhang H., Ge H., Tan B., Yuan Y. et al. IL-27 induces a pro-inflammatory response in human fetal membranes mediating preterm birth. Int. Immunopharmacol. 2017; 50: 361-9.

11. Dutta E.H., Behnia F., Boldogh I., Saade G.R., Taylor B.D., Kacerovský M., Menon R. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol. Hum. Reprod. 2016; 22(2): 143-57.

12. Цхай В.Б., Набережнев Ю.И., Дудина А.Ю., Головченко О.В. Возможности и перспективы применения трансабдоминальной амниоинфузии для пролонгирования беременности при преждевременном разрыве плодных оболочек и маловодии. Акушерство и гинекология. 2016; 11: 5-10. https://dx.doi.org/10.18565/aig.2016.11.5-10 [Tskhai V.B., Naberezhnev Yu.I., Dudina A.Yu., Golovchenko O.V. Transabdominal amnioinfusion for prolongation of pregnancy in premature rupture of membranes and hypamnion: Possibilities and prospects. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2016; (11): 5-10. (in Russian) https://dx.doi.org/10.18565/aig.2016.11.5-10]

13. Souza A.S., Patriota A.F., Guerra G.V., Melo B.C. Evaluation of perinatal outcomes in pregnant women with preterm premature rupture of membranes. Rev. Assoc. Med. Bras. 2016; 62(3): 269-75.

14. Drassinower D., Friedman A.M., Običan S.G., Levin H., Gyamfi-Bannerman C. Prolonged latency of preterm premature rupture of membranes and risk of neonatal sepsis. Am. J. Obstet. Gynecol. 2016; 214(6): 743. e1-6.

15. Hofmeyr G.J., Eke A.C., Lawrie TA. Amnioinfusion for trimester preterm premature rupture of membranes. Cochrane Database Syst. Rev. 2014; (3): CD000942.

16. Roberts D., Vause S., Martin W., Green P., Walkinshaw S., Bricker L. et al. Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet. Gynecol. 2014; 43(5): 490-9.

17. Van Teeffelen S., Pajkrt E., Willekes C., Van Kuijk S.M., Mol B.W. Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks. Cochrane Database Syst. Rev. 2013; (8): CD009952.

18. Tchirikov M., Zhumadilov Z., Winarno A.S., Haase R., Buchmann J. Treatment of preterm premature rupture of membranes with oligo-/anhydramnion colonized by multiresistant bacteria with continuous amnioinfusion and antibiotic administrations through a subcutaneously implanted intrauterine port system: A case report. Fetal Diagn. Ther. 2017; 42(1): 71-6.

19. Tchirikov M., Steetskamp J., Hohmann M., Koelbl H. Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 152(1): 30-3.

20. Козлов П.В., Николаев Н.Н., Дегтярев Д.Н., Луценко Н.Н., Мальцева С.А., Дубинина Е.Н. Влияния длительности безводного промежутка на перинатальные исходы при недоношенной беременности, осложненной преждевременным разрывом плодных оболочек. Здравоохранение и медицинская техника. 2006; 3: 10-1. [Kozlov P.V., Nikolaev N.N., Degtyarev D.N., Lutsenko N.N., Mаltseva S..A, Dubinina E.N. Effects of the duration of the anhydrous gap on perinatal outcomes in preterm pregnancy, complicated by premature rupture of membranes. Health care and medical equipment. 2006; 3 (27): 10-11. (Russian)]

Received 16.08.2017

Accepted 22.09.2017


About the Autors


Tskhay Vitaly B., MD., prof., Head of Department of Perinatology, Obstetrics and Gynecology, Medical Faculty, Krasnoyarsk State Medical University named
after V.F. Voyno-Yasenetsky. 660022, Russia, Krasnoyarsk, P. Zheleznyaka str. 1. Tel.: +79232872134. E-mail: tchai@yandex.ru
Naberezhnev Yury I., M.D., senior researcher, Department of Genetics, Cytology and Bioengineering, Voronezh State University. 394018, Russia, Voronezh,
Universitetskaya pl. 1. Tel.: +79103231247. E-mail: rubick@yandex.ru
Tchirikov Michael N., Prof. MD, PhD, Director of Department of Obstetrics and Prenatal Medicine, Center of Fetal Surgery, University Hospital Halle (Saale),
Martin Luther University Halle-Wittenberg, Halle (Saale), Germany, Ernst-Grube Strasse 40, DE-06120. E-mail: michael.tchirikov@uk-halle.de
Lobanova Tatjana T., Head of Department of Ultrasound and Functional diagnostics, Krasnoyarsk Regional Clinical Center of Maternity and Childhood.
600074, Russia, Krasnoyarsk, Academician Kirensky str. 2A. Теl.: +79131974868. E-mail: oufd_pc@pericentr.ru
Dudina Anna Yu., assistant of Department of Perinatology, Obstetrics and Gynecology, Medical Faculty, V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University; Obstetrician-gynecologist of Department of Pregnancy Pathology Unit №1. Krasnoyarsk Regional Clinical Center of Maternity and Childhood.
660022, Russia, Krasnoyarsk, P. Zheleznyaka str. 1. Tel.: +79131974868. E-mail: anybar@mail.ru
Golovchenko Oleg V., M.D., Associate Professor, Department of Obstetrics and Gynecology Medical Faculty, Belgorod National Research University.
308015, Russia, Belgorod, Pobeda str. 85. Tel.: +79103258807. E-mail: capit68@mail.ru

For citations: Tskhai V.B., Naberezhnev Yu.I., Chirikov M.N., Lobanova T.T., Dudina A.Yu., Golovchenko O.V. Application of continuous amnioinfusion via a subcutaneous port system for premature rupture of membranes and at less than 28 weeks of gestation. The first experience in Russia. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (12): 141-7. (in Russian)
https://dx.doi.org/10.18565/aig.2017.12.141-147


Similar Articles

Бионика Медиа